News
STAT+: Gilead’s Dan O’Day is pharma’s most charming executive — but with his deals falling apart, charm may not be enough
Gilead’s Dan O’Day has charisma and charm. What he lacks lately are clear wins in drug development. […]
BiotechMatt’s TakebiotechnologycancerSTAT+
